IRIS Tipologia:https://hdl.handle.net/10807/2092026-07-14T13:32:54Z2026-07-14T13:32:54ZHow long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hostshttps://hdl.handle.net/10807/3427172026-07-14T06:15:01Z2026-01-01T00:00:00ZTitolo: How long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hosts
Autori: Mazzitelli M.; Serraino R.; Trecarichi E. M.; Murri R.; Torti C.2026-01-01T00:00:00ZImpact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Studyhttps://hdl.handle.net/10807/3425772026-07-11T01:12:54Z2026-01-01T00:00:00ZTitolo: Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study
Autori: Cefalo, Jacopo; Varone, Francesco; Luppi, Fabrizio; Cameli, Paolo; Cerri, Stefania; Puci, Mariangela Valentina; Martini, Alessia; Franco, Giovanni; Zanini, Umberto; Pianigiani, Tommaso; Patsoura, Athina; Richeldi, Luca; Bargagli, Elena; Sotgiu, Giovanni; Mondoni, Michele
Abstract: none2026-01-01T00:00:00ZASO Author Reflections: Beyond the Limits of Classic Hepatectomies: Ultrasound-Guided Parenchyma-Sparing Liver Resectionshttps://hdl.handle.net/10807/3422592026-07-08T23:11:01Z2026-01-01T00:00:00ZTitolo: ASO Author Reflections: Beyond the Limits of Classic Hepatectomies: Ultrasound-Guided Parenchyma-Sparing Liver Resections
Autori: Giuliante F.; Famularo S.2026-01-01T00:00:00ZMachine Learning-Based Treatment Allocation for Recurrent Hepatocellular Carcinoma - Replyhttps://hdl.handle.net/10807/3422582026-07-08T23:11:14Z2023-01-01T00:00:00ZTitolo: Machine Learning-Based Treatment Allocation for Recurrent Hepatocellular Carcinoma - Reply
Autori: Famularo S.; Donadon M.; Torzilli G.2023-01-01T00:00:00Z